Search filters

List of works by Jeppe Sturis

Alternative insulin delivery systems: how demanding should the patient be?

scientific article published on July 1, 1997

Beta-cell selective K(ATP)-channel activation protects beta-cells and human islets from human islet amyloid polypeptide induced toxicity.

scientific article

Changes in Pancreatic Islet Glucokinase and Hexokinase Activities With Increasing Age, Obesity, and the Onset of Diabetes

scientific article published on 01 September 1997

Combination of the insulin sensitizer, pioglitazone, and the long-acting GLP-1 human analog, liraglutide, exerts potent synergistic glucose-lowering efficacy in severely diabetic ZDF rats.

scientific article published in April 2008

Elucidating the Mechanism of Absorption of Fast-Acting Insulin Aspart: The Role of Niacinamide

scientific article published on 11 February 2019

Evolution of β-Cell Dysfunction in the Male Zucker Diabetic Fatty Rat

scientific article published on 01 December 1995

Explorative study of pharmacokinetics and pharmacodynamics after change in basal insulin infusion rate.

scientific article

Fast-acting insulin aspart (Fiasp®) improves glycemic outcomes when used with MiniMedTM 670G hybrid closed-loop system in simulated trials compared to NovoLog®

scientific article published on 08 April 2021

Generic bifurcation structures of Arnol'd tongues in forced oscillators

scientific article published on 01 September 1991

Glucose- and interleukin-1beta-induced beta-cell apoptosis requires Ca2+ influx and extracellular signal-regulated kinase (ERK) 1/2 activation and is prevented by a sulfonylurea receptor 1/inwardly rectifying K+ channel 6.2 (SUR/Kir6.2) selective po

scientific article published in July 2004

Hypoglycemic thresholds for cognitive dysfunction in IDDM

scientific article published on 01 March 1992

Improved beta-cell survival and reduced insulitis in a type 1 diabetic rat model after treatment with a beta-cell-selective K(ATP) channel opener.

scientific article published in April 2004

Insulin detemir is a fully efficacious, low affinity agonist at the insulin receptor.

scientific article published in August 2010

Insulin secretion in insulin-resistant women with a history of gestational diabetes

scientific article published on August 1, 1995

Measurements of insulin responses as predictive markers of pancreatic beta-cell mass in normal and beta-cell-reduced lean and obese Göttingen minipigs in vivo.

scientific article published on 8 November 2005

NN414, a SUR1/Kir6.2-Selective Potassium Channel Opener, Reduces Blood Glucose and Improves Glucose Tolerance in the VDF Zucker Rat

scientific article published on October 1, 2003

One week's treatment with the long-acting glucagon-like peptide 1 derivative liraglutide (NN2211) markedly improves 24-h glycemia and alpha- and beta-cell function and reduces endogenous glucose release in patients with type 2 diabetes.

scientific article published in May 2004

Pharmacokinetics and pharmacodynamics of different modes of insulin pump delivery. A randomized, controlled study comparing subcutaneous and intravenous administration of insulin aspart

scientific article published on 01 February 2011

The conscious Göttingen minipig as a model for studying rapid pulsatile insulin secretion in vivo.

scientific article